|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of ustekinumab,a human interleukin-12/23 monoclonal antibody,in patients with psoriasis:76-week result from randomized,double-blind,Placebo-controlled trial显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 2 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in pa- tients with psoriasis: 76-week results fi'om a randomised, dou- ble-blind, placebo-controlled trial (PHOENIX 1)显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 3 | Efficacy and safety of ustekinumab,a human interleukin-12/23 mono- clonal antibody,in patients with psoriasis: 76-week resuhs from a randomised, doubleblind, placebo-controlled trial (PHOENIX 1 ) 显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 4 | Cutaneous reactions following herpes zoster infections: report of three cases and a review of the literature显示文摘 | Gibney MD Nahass GT Leonardi CL | 1996 | Br J Dermatol1996，134，3： | 1 |
| 5 | Clinical re- sponse in psoriasis patients discontinued from and then re- initiated on etanercept therapy显示文摘 | Gordon KB Gottlieb AB Leonardi CL | 2006 | J Dermatolog Treat2006，17，1： | 1 |
| 6 | Etanercept as monotherapy in patients with psoriasis 显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，21： | 1 |
| 7 | Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis 显示文摘 | Menter A Gordon KB Leonardi CL | 2010 | J Am Acad Dermato12010，63，3： | 1 |
| 8 | Extended efalizumab therapy in improves chronic plaque psoriasis:Results from a randomized phase III trial显示文摘 | Leonardi CL Papp KA Gordon KB | 2005 | J AM ACAD Dermatol2005，52，3： | 1 |
| 9 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis:76-week results from s randomized, double-blind, placebo-controlled trial (PHOENIX1) 显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 10 | Cutaneous reactions following herpes zoster infections: report of three cases and a review of the literature显示文摘 | Gibney D Nahass GT Leonardi CL | 1996 | Br J Dermatol1996，134，3： | 1 |
| 11 | Etanereept as mono- therapy in patients with psoriasis 显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，21： | 1 |
| 12 | Etanercept as monotherapy in patients with psoriasis显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，21： | 1 |
| 13 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody in patients with psoriasis :76-week results from a randomised, double- blind, placebo-controlled trial ( PHOENIX 1 ) 显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 14 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week resuits from a randomised, double-blind, placebo-controlled trial 显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 15 | Etanercept as monotherapy in patients with psoriasis 显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，21： | 1 |
| 16 | Etanercept as monotherapy in patients with psoriasis显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，： | 1 |
| 17 | Efficacy and safety of ustekinnmab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1 )显示文摘 | Leonardi CL Kimball AB Papp KA | 2008 | Lancet2008，371，9625： | 1 |
| 18 | Etanercept as monotherapy in patients with psoriasis显示文摘 | Leonardi CL Powers JL Matheson RT | 2003 | N Engl J Med2003，349，21： | 1 |
| 19 | Integrated safety analysis:short-and long-term safety profiles of etanercept in patients with psoriasis显示文摘 | Pariser DM Leonardi CL Gordon K | 2012 | J Am Acad Dermatol2012，67，2： | 1 |
| 20 | Etanercept as monotherapy in patients with psoriasis 显示文摘 | Powers JL Matheson RT | 2003 | N Engl J Med2003，349，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员